1.Implication of expression of Nanog in prostate cancer cells and their stem cells.
Chen, GONG ; Hui, LIAO ; Fengjin GUO ; Liang, QIN ; Jun, QI
Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(2):242-6
Recent studies suggested that the prostate cancer may arise from prostate cancer stem cells that share some same characteristics with normal stem cells. The purpose of this study was to detect the differences of Nanog expression between PC3 prostate cancer cell line and its tumor stem cells, and the relationship was preliminarily examined between Nanog and prostate cancer and its tumor stem cells. By using magnetic active cell sorting (MACS), we isolated a population of CD44(+)/CD133(+) prostate cancer cells that display stem cell characteristics from PC3 cell line. Immunohistochemistry revealed positive expressions of CD44, CD133 and α(2)β(1)-integin in the isolated cells. CCK-8 analysis showed that isolated cells had a strong proliferative ability. The formation of the cell spheres in serum-free medium and holoclones in serum-supplied medium showed that the cells were capable of self-renewing, indicating that the isolated cells were a population of cancer stem-like cells derived from PC3 cell line. Western blotting exhibited that the isolated cells had higher experession of Nanog, an embryonic stem marker, as compared with PC3 cells. Our study showed that Nanog might be helpful in sustaining the self-renewal and the undifferentiation of prostate cancer stem cells, and may serve as a marker for prostate cancer stem cells for isolation and identification.
2.Effects of Qingrehuayuziyin Fang on lymphocyte apoptosis and expression of Fas and FasL in peripheral blood in the patients with systemic lupus erythematosus
Wei LIANG ; Lin JIN ; Ling GONG ; Liling ZHANG ; Hui LIAO ; Ying CAI
Chinese Journal of Clinical Pharmacology and Therapeutics 2004;0(09):-
AIM: To investigate the effect of Qingrehuayuziyin Fang on lymphocyte apoptosis and expression of Fas and FasL in peripheral blood in the patients with systemic lupus erythematosus(SLE).METHODS: Eighty patients with SLE were selected and divided randomly into two groups,40 in the therapy group and 40 in control group respectively.Patients were get the treatment of Qingrehuayuziyin Fang combined hormone(prednisone) as therapy group and get hormone treating only as control group.After treating three months,lymphocyte were collected to be detected the rate of apoptosis by flow cytometer.Meanwhile,the expression of Fas and FasL were analyzed by RT-PCR.RESULTS: After three months treating,the rate of lymphocyte apoptosis was decreased significantly in therapy group compared with that in control group(P
4.Therapeutical Effects of Rehmannia and Storesin on Minimal Hepatic Encephalopathy in Rat Mode
He LIU ; Yan LIANG ; Yanyong LIU ; Nan YANG ; Chao JI ; Pingping ZUO ; Tao GONG ; Lei LIAO ; Xiaoming HOU ; Zhe CAI
Chinese Journal of Rehabilitation Theory and Practice 2010;16(10):904-906
ObjectiveTo assess the effects of rehmannia and storesin on minimal hepatic encephalopathy(MHE) in rat model.MethodsMHE rat model was induced by carbon tetrachloride (CCl4) intragastric administration. The effects of rehmannia and storesin on spontaneous movement and learning and memory function of model animals were evaluated with open field test and Morris water maze in 3 dose groups. Lactulose was used in the positive group.ResultsThe spontaneous movement and the spatial learning and memory ability of the model rats both improved significantly in the high dose group. Meanwhile, the serum level of alanine transarninase(ALT) and ammonia(Amm) also decreased in the high dose group.ConclusionRehmannia and storesin has therapeutical effect on MHE rat model.
5.Implication of Expression of Nanog in Prostate Cancer Cells and Their Stem Cells
GONG CHEN ; LIAO HUI ; GUO FENGJIN ; QIN LIANG ; QI JUN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(2):242-246
Recent studies suggested that the prostate cancer may arise from prostate cancer stem cells that share some same characteristics with normal stem cells.The purpose of this study was to detect the differences of Nanog expression between PC3 prostate cancer cell line and its tumor stem cells,and fhe relationship was preliminarily examined between Nanog and prostate cancer and its tumor stem cells.By using magnetic active cell sorting (MACS),we isolated a population of CD44+/CD133+ prostate cancer cells that display stem cell characteristics from PC3 cell line.lmmunohistochemistry revealed positive expressions of CD44,C D 133 and α2β1-integin in the isolated cells.CCK-8 analysis showed that isolated cells had a strong proliferafive ability.The formation of the cell spheres in serum-free medium and holoclones in serum-supplied medium showed that the cells were capable of self-renewing,indicating that the isolated cells were a population of cancer stem-like cells derived from PC3 cell line.Western blotting exhibited that the isolated cells had higher experession of Nanog,an embryonic stem marker,as compared with PC3 cells.Our study showed that Nanog might be helpful in sustaining the self-renewal and fhe undifferentiation of prostate cancer stem cells,and may serve as a marker for prostate cancer stem cells for isolation and identification.
6.Clinical trial of ginsenoside Rh2 combined with concurrent radiotherapy and chemotherapy in the treatment of patients with nasopharyngeal carcinoma
Cheng GONG ; Liang-Bo LI ; Yong LIAO ; Jun-Wu TAN ; Xue-Qiu CAO
The Chinese Journal of Clinical Pharmacology 2017;33(23):2449-2451
Objective To evaluate the clinical efficacy and safety of ginsenoside Rh2 combined with concurrent radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma.Methods A total of 123 cases of non-keratinized undifferentiated nasopharyngeal carcinoma (stage Ⅲ-Ⅳ A) were divided into treatment group (n =63 cases) and control group (n =60 cases).Control group was received concurrent radiotherapy and chemotherapy and conventional symptomatic support therapy,6MV X radiation,the original lesion dose of 66-76 Gy,lymph node metastasis treated with 60-70 Gy,56-60 Gy of neck prevention,5 times a week;intravenous infusion of cisplatin 30 mg · m-2,once a week.Treatment group was orally administration of ginsenoside Rh2 250 mg on the basis of control group.The two groups were treated for 6 weeks.The short-term efficacy was evaluated by reference to the sohd tumor evaluation criteria (RECIST).The overall survival rate was followed for 2 years.The safety evaluation was conducted according to the World Health Organization (WHO) evaluation criteria for adverse drug resistance.Results After treatment,the objective response rates in treatment group and control group were 95.24% (60 cases/63 cases),78.33% (14 cases/60 cases),with significant difference (P <0.05).The disease control rates in treatment group and control group were 98.41% (62 cases/63 cases),93.33% (56 cases/60 cases),with significant difference (P<0.05).The overall survival rates in treatment group and control group were 90.48% (57 cases/63 cases),76.67% (46 cases/60 cases),with significant difference (P <0.05).The incidences of adverse reactions in treatment group and control group were 39.68%,58.33%,with significant difference (P < 0.05).Conclusion The clinical efficacy and safety of ginsenoside Rh2 combined with concurrent radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma were better than those of simple concurrent radiotherapy and chemotherapy.
7.Evaluation on the safety of a group A + C meningococcal polysaccharide vaccine.
Bai-qing DONG ; Qiang YE ; Xuan-lin CUI ; Jin YANG ; Jian GONG ; Ming YANG ; He-zhuang LIAO ; Shi-liang WEI ; Jie ZHANG ; Xing-hua WU ; Guo-ai SI ; Hong-hui YANG ; Ataru TSUZUKI ; JinKyung PARK ; Mohammad ALI ; Leon R OCHIAI ; John D CLEMENS
Chinese Journal of Epidemiology 2007;28(5):417-421
OBJECTIVETo evaluate the safety of a group A + C meningococcal polysaccharide vaccine as part of a phase IV clinical trial.
METHODSThe study area was divided into 108 clusters according to the principle of cluster randomization, stratified and paired sampling methods. 54 out of 108 clusters served as observation groups were administered A + C vaccine, while the rest 54 groups were administered Vi polysaccharide vaccine. An adverse event surveillance system was established to monitor the adverse events following the vaccination campaign. Identical form and methods were used for data collection to investigate the adverse events following the vaccination of both A+ C vaccine and Vi vaccine.
RESULTS34,543 people were vaccinated, including 18,167 of whom received A + C vaccine, while the other 16,376 received Vi vaccine. The rates of immediate injection reaction and unsolicited non-serious adverse events from A + C vaccine group were 0.44% and 0.38% while of Vi vaccine group were 0.79% and 0.73% respectively. At the solicited adverse event survey on 3-day-post-vaccination, 1239 vaccinees were followed-up including 771 received A + C vaccine and 468 received Vi vaccine. The local injection reaction rate of A + C vaccine group on the 1st day was significantly higher (X2 = 13.98, P = 0.0002) than that of Vi vaccine group. Neither the local injection reaction rate nor the system reaction rate between both groups was significantly different on 2nd and 3rd day, post vaccination. It was not statistically different when comparing fever onset rate between those who received vaccine and those who did not, in each vaccine group. There were no serious adverse events observed.
CONCLUSIONResults showed that the side effects of A + C vaccine and the Vi vaccine were mild and safe for vaccination campaigns targeting on populations at different age.
Adolescent ; Adult ; Age Distribution ; Child ; Child, Preschool ; Female ; Humans ; Male ; Meningococcal Vaccines ; adverse effects ; immunology ; Middle Aged ; Polysaccharides, Bacterial ; immunology ; Sex Distribution ; Young Adult
8.Expert Consensus on Evaluation, Treatment and Rehabilitation of Traumatic Spinal Cord Injury
Jianjun LI ; Mingliang YANG ; Degang YANG ; Feng GAO ; Liangjie DU ; Limin LIAO ; Bohua CHEN ; Fang ZHOU ; Xuesong ZHANG ; Tiansheng SUN ; Baozhong ZHANG ; Xiaopei XIANG ; Lixia CHEN ; Hongjun ZHOU ; Songhuai LIU ; Zhihan SUN ; Ying LIU ; Xuan LIU ; Chunying HU ; Qiuchen HUANG ; Juan WU ; Fubiao HUANG ; Xiaoying ZHANG ; Jun LI ; Liang CHEN ; Hongwei LIU ; Huiming GONG
Chinese Journal of Rehabilitation Theory and Practice 2017;23(3):274-287
Spinal cord injury is a catastrophic injury causing lifelong severe disabilities, and poses a great burden to the individuals, families and society. In order to promote the standardization in treatment of traumatic spinal cord injury, the consensus on the evaluation, treatment and rehabilitation of traumatic spinal cord injury was suggested by experts, who came from authoritative multicenter in China. The expert consensus, which formed a standardization process from the first aid clinical treatment to rehabilitation of spinal cord injury, shall give a better practical guide for clinic and rehabilitation physicians.
9.Seminal vesiculoscopy: Past, status quo, and prospects.
Qi WANG ; Liang-Gong LIAO ; Yan-Feng LI
National Journal of Andrology 2017;23(11):1038-1042
Seminal vesiculoscopy is a new technology in uro-andrology developed in recent 10 years, which is a set of clinical operational techniques for observing the ejaculatory duct, seminal vesicle, ampullar region of the vas deferens and their surrounding structure, determining the cause, location and degree of the disease, and accomplishing such treatment procedures as irrigation, resection, incision, fulguration, hemostasis, expansion, drainage, and removal of hematocele, stones or obstruction in the distal seminal duct region. Therefore, it is not only an etiologically diagnostic technique, but also a minimally invasive surgical approach to the management of common diseases of the distal seminal duct region. Seminal vesiculoscopy has irreplaceable advantages of safety, effectiveness, minimal invasiveness, rapid recovery, and few complications.
Calculi
;
diagnostic imaging
;
surgery
;
Drainage
;
Ejaculatory Ducts
;
diagnostic imaging
;
Endoscopy
;
methods
;
Genital Diseases, Male
;
diagnostic imaging
;
surgery
;
Hematocele
;
diagnostic imaging
;
surgery
;
Humans
;
Male
;
Minimally Invasive Surgical Procedures
;
Seminal Vesicles
;
diagnostic imaging
;
Vas Deferens
;
diagnostic imaging
10.Vacuum sealing drainage as an adjuvant treatment of penile and scrotal gangrene: Clinical analysis of 4 cases.
Tong ZHU ; Liang-Gong LIAO ; Yan-Feng LI ; Xu-Dong LIU ; Ming HU ; Yong ZHANG ; Zhong-Tai LI ; Quan-Fu CAO ; Jun JIANG
National Journal of Andrology 2017;23(3):237-242
Objective:
To search for an optimal strategy for the treatment of penile and scrotal gangrene by analyzing the clinical effect of vacuum sealing drainage (VSD) as an adjuvant treatment on this disease.
METHODS:
We retrospectively analyzed the clinical data about 4 cases of penile and scrotal gangrene treated by VSD as an adjuvant treatment from January 2015 to June 2016. The 4 patients all underwent early extensive and radical debridement of gangrene of the scrotum and penis and received intravenous injection of two broad-spectrum antibiotics, followed by VSD for wound drainage and irrigation.
RESULTS:
Adequate wound drainage was achieved in all the 4 cases, the gangrene range rapidly localized and testicular necrosis avoided. The wound surface healed satisfactorily after cleansing and suturing. The patients were followed up for 3 months after discharged from the hospital and none experienced recurrence.
CONCLUSIONS
VSD combined with early adequate debridement can effectively localize the gangrene range, significantly reduce the frequency of changing dressings and shorten the hospitalization time of the patient, and therefore is a very effective adjuvant treatment of penile and scrotal gangrene.
Debridement
;
Gangrene
;
therapy
;
Genital Diseases, Male
;
pathology
;
prevention & control
;
therapy
;
Humans
;
Male
;
Negative-Pressure Wound Therapy
;
methods
;
Penis
;
pathology
;
Retrospective Studies
;
Scrotum
;
pathology
;
Testis
;
pathology
;
Treatment Outcome
;
Vacuum